NOTCH3 and lung adenocarcinoma: In addition, Notch3 was also associated with the overall survival rate of lung adenocarcinoma patients (pooled HR = 1.33, 95%CI: 1.07-1.67, p = 0.269 and I2 = 22.8%) (Fig. 4B).